Cargando…

May Measurement Month 2017: an analysis of blood pressure screening results in Nepal—South Asia

Hypertension is the leading risk factor of mortality in Nepal accounting for ∼33 000 deaths in 2016. However, more than 50% of the hypertensive patients are unaware of their status. We participated in the May Measurement Month 2017 (MMM17) project initiated worldwide by the International Society of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Shiva Raj, Shrestha, Nipun, Poudyal, Indra Prasad, Malla, Milan, Gyawali, Bishal, Shrestha, Aamod Dhoj, Pokharel, Shashank, Gyawali, Madan, Sapkota, Surendra, Bhattarai, Harikrishna, Dhakal, Liladhar, Soti, Pabitra Babu, Ghimire, Sagar, Paudel, Rajan, Xia, Xin, Beaney, Thomas, Koirala, Sweta, Olsen, Michael Hecht, Poulter, Neil R, Kallestrup, Per, Neupane, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479435/
https://www.ncbi.nlm.nih.gov/pubmed/31043887
http://dx.doi.org/10.1093/eurheartj/suz063
Descripción
Sumario:Hypertension is the leading risk factor of mortality in Nepal accounting for ∼33 000 deaths in 2016. However, more than 50% of the hypertensive patients are unaware of their status. We participated in the May Measurement Month 2017 (MMM17) project initiated worldwide by the International Society of Hypertension to raise the awareness on the importance of blood pressure (BP) screening. In this paper, we discuss the screening results of MMM17 in Nepal. An opportunistic cross-sectional survey of volunteers aged ≥18 years was carried out in May 2017 following the standard MMM protocol. Data were collected from 18 screening sites in 7 districts covering 5 provinces. Screenings were conducted either in health facilities, public places, or participants’ homes. Trained volunteers with health science background and female community health volunteers were mobilized to take part in the screening. A total of 5972 individuals were screened and of 5968 participants, for whom a mean of the 2nd and 3rd readings was available, 1456 (24.4%) participants had hypertension; 908 (16.8%) of those not receiving treatment were hypertensive; and 248 (45.2%) of those being treated had uncontrolled BP. MMM17 is the first nationwide BP screening campaign undertaken in Nepal. Given the suboptimal treatment and control rates identified in the study, there is a strong imperative to scale up hypertension prevention, screening, and management programmes. These results suggest that opportunistic screening can identify significant numbers with hypertension. Mobilization of existing volunteer networks and support of community stakeholders, would be necessary to improve the overall impact and sustainability of future screening programmes.